Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

导出 LinkOut

翻译打印收藏纠错

第一作者： Muhammet,Bekir Hacioglu

第一单位： Department of Medical Oncology, Trakya University, Medicine Faculty, Edirne, Turkey.

作者： Muhammet,Bekir Hacioglu ^[1] ; Osman,Kostek ; Senem,Karabulut ; Didem,Tastekin ; Sema,Sezgin Goksu ; Celal,Alandag ; Baran,Akagunduz ; Irem,Bilgetekin ; Burcu,Caner ; Ahmet,Bilgehan Sahin ; Birol,Yildiz ; Fatih,Kose ; Muhammet Ali,Kaplan ; Ahmet,Gulmez ; Ender,Dogan ; Deniz,Can Guven ; Mustafa,Gurbuz ; Yakup,Ergun ; Mustafa,Karaagac ; Atike,Gokcen Demiray ; Sema,Turker ; Teoman,Sakalar ; Ozlem,Ozkul ; Tugba Akin,Telli ; Suleyman,Sahin ; Saadettin,Kilickap ; Ahmet,Bilici ; Bulent,Erdogan ; Irfan,Cicin

作者单位： Department of Medical Oncology, Trakya University, Medicine Faculty, Edirne, Turkey. ^[1]

主题词老年人(Aged);癌, 肝细胞(Carcinoma, Hepatocellular);女(雌)性(Female);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);苯脲化合物(Phenylurea Compounds);吡啶类(Pyridines);回顾性研究(Retrospective Studies);土耳其(Turkey)

PMID 33099930

发布时间 2021-07-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of B.U.ON.

1897-1903页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

Journal of B.U.ON.

相似文献

Journal of B.U.ON.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

Journal of B.U.ON.

相似文献

Journal of B.U.ON.

相关期刊

检索历史清除